Fri 25'th May 2018
Xenon Pharmaceuticals Inc. Stock Analysis
Technical stock analysis for Fri 25'th May 2018
No changes to the price of Xenon Pharmaceuticals Inc. in the last trading day. The price has fallen in 5 of the last 10 days and is down by -5.98% for this period.
|Shorts||1.17% ( 2018-04-30 )|
Xenon Pharmaceuticals Inc. has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $5.53. A reaction back to this level may hold a second chance to get out before further falls.
There are mixed signals in the stock today. Xenon Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $5.82 and $5.66. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". A buy signal was issued from a pivot bottom point on Thursday May 24, 2018, which indicates further gains until a new top pivot has been found.
Relative Strength Index (RSI)
RSI14 is 41 and the stock is currently not being overbought or oversold
Support & Resistance
Xenon Pharmaceuticals Inc. finds support from accumulated volume at $5.45.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.35 between high and low, or 6.67%. For the last week the stock has had a daily average volatility of 7.66%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Xenon Pharmaceuticals Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
Trade XENE CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder